Search Results

Filter
  • 1-10 of  40,745 results for ""Hypoglycemic Agents therapeutic use""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Genitourinary Tract Infections in Patients Taking SGLT2 Inhibitors: JACC Review Topic of the Week.

  • Authors : Kittipibul V; Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA; Duke Clinical Research Institute, Durham, North Carolina, USA. Electronic address: https://twitter.com/vkittipibul.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/etiology

  • Source: Journal of the American College of Cardiology [J Am Coll Cardiol] 2024 Apr 23; Vol. 83 (16), pp. 1568-1578.Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evaluation of a hybrid protocol using continuous glucose monitoring and point-of-care testing in non-critically ill patients in a community hospital.

Subjects: Blood Glucose* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2024 Apr 19; Vol. 81 (9), pp. e261-e267.Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Glycemia and Gluconeogenesis With Metformin and Liraglutide: A Randomized Trial in Youth-onset Type 2 Diabetes.

  • Authors : Dietsche KB; National Institute of Diabetes, Digestive and Kidney Diseases/National Institutes of Health, Bethesda, MD 20892, USA.; Magge SN

Subjects: Metformin*/Metformin*/Metformin*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Female

  • Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Apr 19; Vol. 109 (5), pp. 1361-1370.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

PPAR agonists as add-on treatment with metformin in management of type 2 diabetes: a systematic review and meta-analysis.

  • Authors : Alnuaimi S; College of Medicine and Health Sciences, Khalifa University, PO Box 127788, Abu Dhabi, United Arab Emirates.; Reljic T

Subjects: Metformin*/Metformin*/Metformin*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/chemically induced

  • Source: Scientific reports [Sci Rep] 2024 Apr 16; Vol. 14 (1), pp. 8809. Date of Electronic Publication: 2024 Apr 16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Sodium Glucose Transporter 2 Inhibitors Versus Metformin on Cardiovascular and Renal Outcomes in Patients With Diabetes With Low Cardiovascular Risk: A Nationwide Cohort Study.

  • Authors : Chang HC; Department of Medicine Taipei Veterans General Hospital Taoyuan Branch Taoyuan Taiwan.; Cardiovascular Research Center, School of Medicine National Yang Ming Chiao Tung University Taipei Taiwan.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Metformin*/Metformin*/Metformin*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: Journal of the American Heart Association [J Am Heart Assoc] 2024 Apr 16; Vol. 13 (8), pp. e032397. Date of Electronic Publication: 2024 Apr 09.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Population Trends of New Prescriptions for Antihyperglycemics and Antihypertensives Between 2014 and 2022.

  • Authors : Yu AYX; Department of Medicine (Neurology) University of Toronto, Sunnybrook Health Sciences Centre Toronto ON Canada.; ICES Toronto ON Canada.

Subjects: Antihypertensive Agents*/Antihypertensive Agents*/Antihypertensive Agents*/therapeutic use ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use; Humans

  • Source: Journal of the American Heart Association [J Am Heart Assoc] 2024 Apr 16; Vol. 13 (8), pp. e034118. Date of Electronic Publication: 2024 Apr 02.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Possible role of metformin as an antidepressant in diabetes.

  • Authors : Pedreañez A; Cátedra de Inmunología, Escuela de Bioanálisis, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela.; Carrero Y

Subjects: Metformin*/Metformin*/Metformin*/pharmacology ; Metformin*/Metformin*/Metformin*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Journal of affective disorders [J Affect Disord] 2024 Apr 15; Vol. 351, pp. 349-355. Date of Electronic Publication: 2024 Jan 28.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7906073 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Total Pancreatectomy in a Patient Treated with a Sensor-augmented Pump Showing No Evidence of Hyperglycemia or Ketoacidosis without Any Insulin Administration.

  • Authors : Ito H; Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan.; Yamada E

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Hyperglycemia*/Hyperglycemia*/Hyperglycemia*/drug therapy ; Hyperglycemia*/Hyperglycemia*/Hyperglycemia*/etiology

  • Source: Internal medicine (Tokyo, Japan) [Intern Med] 2024 Apr 15; Vol. 63 (8), pp. 1125-1130. Date of Electronic Publication: 2023 Sep 01.Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials.

  • Authors : Mellbin LG; Department of Medicine Solna, Karolinska Institutet, Eugeniavägen 27, 171 64 Solna, Stockholm, Sweden.; Heart Vascular and Neuro Theme, Karolinska University Hospital, K2 Medicin, K2 Kardio Pernow J, 171 77 Solna, Stockholm, Sweden.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Cardiovascular System*

  • Source: European heart journal [Eur Heart J] 2024 Apr 14; Vol. 45 (15), pp. 1371-1374.Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Intensive management from diagnosis improves HbA1c at 12 months post-diagnosis: results from a prospective cohort study in children with newly diagnosed type 1 diabetes.

  • Authors : Griffin C; Department of Paediatrics, Te Whatu Ora, Waitaha, New Zealand.; Roxburgh E

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/diagnosis ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy; Child

  • Source: The New Zealand medical journal [N Z Med J] 2024 Apr 12; Vol. 137 (1593), pp. 14-30. Date of Electronic Publication: 2024 Apr 12.Publisher: Pasifika Medical Association Group Country of Publication: New Zealand NLM ID: 0401067 Publication Model: Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  40,745 results for ""Hypoglycemic Agents therapeutic use""